Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Respiratory Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Respiratory Drugsmarket, defines the market attractiveness level of Respiratory Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Respiratory Drugs industry, describes the types of Respiratory Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Respiratory Drugs market and the development prospects and opportunities of Respiratory Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Respiratory Drugs market in Chapter 13.
By Player:
Dr Reddy's Laboratories
Horizon Pharma
Amgen
Pfizer
Dainippon Sumitomo
Abbott
FibroGen
Afferent Pharmaceuticals
By Type:
Asthma
Chronic Obstructive Pulmonary Disease
Idiopathic Pulmonary Fibrosis
Cystic Fibrosis
By End-User:
Hospitals
Ambulatory Care
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Respiratory Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Respiratory Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Respiratory Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Respiratory Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Respiratory Drugs Market Analysis and Outlook to 2022
-
7.1 Global Respiratory Drugs Consumption (2017-2022)
-
7.2 United States Respiratory Drugs Consumption (2017-2022)
-
7.3 Europe Respiratory Drugs Consumption (2017-2022)
-
7.4 China Respiratory Drugs Consumption (2017-2022)
-
7.5 Japan Respiratory Drugs Consumption (2017-2022)
-
7.6 India Respiratory Drugs Consumption (2017-2022)
-
7.7 South Korea Respiratory Drugs Consumption (2017-2022)
8 Region and Country-wise Respiratory Drugs Market Analysis and Outlook to 2028
-
8.1 Global Respiratory Drugs Consumption Forecast (2022-2028)
-
8.2 United States Respiratory Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Respiratory Drugs Consumption Forecast (2022-2028)
-
8.4 China Respiratory Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Respiratory Drugs Consumption Forecast (2022-2028)
-
8.6 India Respiratory Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Respiratory Drugs Consumption Forecast (2022-2028)
9 Global Respiratory Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Respiratory Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Asthma Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chronic Obstructive Pulmonary Disease Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Idiopathic Pulmonary Fibrosis Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Cystic Fibrosis Consumption and Growth Rate (2017-2022)
-
9.2 Global Respiratory Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ambulatory Care Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Respiratory Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Respiratory Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Asthma Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Chronic Obstructive Pulmonary Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Idiopathic Pulmonary Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Cystic Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Respiratory Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ambulatory Care Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Respiratory Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Respiratory Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Respiratory Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Respiratory Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Respiratory Drugs Market Competitive Analysis
-
14.1 Dr Reddy's Laboratories
-
14.1.1 Dr Reddy's Laboratories Company Details
-
14.1.2 Dr Reddy's Laboratories Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Dr Reddy's Laboratories Respiratory Drugs Product and Service
-
14.2 Horizon Pharma
-
14.2.1 Horizon Pharma Company Details
-
14.2.2 Horizon Pharma Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Horizon Pharma Respiratory Drugs Product and Service
-
14.3 Amgen
-
14.3.1 Amgen Company Details
-
14.3.2 Amgen Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Amgen Respiratory Drugs Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Respiratory Drugs Product and Service
-
14.5 Dainippon Sumitomo
-
14.5.1 Dainippon Sumitomo Company Details
-
14.5.2 Dainippon Sumitomo Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Dainippon Sumitomo Respiratory Drugs Product and Service
-
14.6 Abbott
-
14.6.1 Abbott Company Details
-
14.6.2 Abbott Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Abbott Respiratory Drugs Product and Service
-
14.7 FibroGen
-
14.7.1 FibroGen Company Details
-
14.7.2 FibroGen Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 FibroGen Respiratory Drugs Product and Service
-
14.8 Afferent Pharmaceuticals
-
14.8.1 Afferent Pharmaceuticals Company Details
-
14.8.2 Afferent Pharmaceuticals Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Afferent Pharmaceuticals Respiratory Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Respiratory Drugs
-
Figure Respiratory Drugs Picture
-
Table Global Respiratory Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Respiratory Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Respiratory Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Respiratory Drugs Consumption by Country (2017-2022)
-
Figure United States Respiratory Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Respiratory Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Respiratory Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Respiratory Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Respiratory Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Respiratory Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Respiratory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Respiratory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Respiratory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Respiratory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Respiratory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Respiratory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Asthma Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Obstructive Pulmonary Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Idiopathic Pulmonary Fibrosis Consumption and Growth Rate (2017-2022)
-
Figure Global Cystic Fibrosis Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Care Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Asthma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Obstructive Pulmonary Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Idiopathic Pulmonary Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cystic Fibrosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Respiratory Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Respiratory Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy's Laboratories Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Laboratories Respiratory Drugs Product and Service
-
Table Horizon Pharma (Foundation Year, Company Profile and etc.)
-
Table Horizon Pharma Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Horizon Pharma Respiratory Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Respiratory Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Respiratory Drugs Product and Service
-
Table Dainippon Sumitomo (Foundation Year, Company Profile and etc.)
-
Table Dainippon Sumitomo Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dainippon Sumitomo Respiratory Drugs Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Respiratory Drugs Product and Service
-
Table FibroGen (Foundation Year, Company Profile and etc.)
-
Table FibroGen Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table FibroGen Respiratory Drugs Product and Service
-
Table Afferent Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Afferent Pharmaceuticals Respiratory Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Afferent Pharmaceuticals Respiratory Drugs Product and Service
-
